Precision sample processing, purpose-built for Australian drug discovery.
Underpinned by advanced automation, rigorous quality systems, and highly optimised workflows, Compounds Australia's sample processing capability delivers the precision, flexibility, and reliability required for modern drug discovery.
Developed through more than 20 years of supporting drug discovery programs across academia and industry, we provide researchers with a trusted, scalable service that reduces operational complexity and accelerates discovery.
Our sample processing platforms
Our custom sample processing platforms support dispensing in flexible, assay-ready formats, spanning nanolitre to microlitre volumes and enabling efficient integration into a broad range of screening workflows. Sample processing platforms are completed with accessory devices tailored to each platform, enabling full end-to-end workflow processing and environmental control pre- and post- processing.
Fully automated processing
Direct integration to sample stores and accessory devices reduces the need for manual intervention.
Rapid, accurate, secure and flexible
Designed to support diverse research needs, compounds can be processed and dispensed into 96-, 384-, and 1536-well microplates with speed, precision, and traceability.
Assay-ready formats
We support single-point screening, dose-response, serial dilutions, combination matrices and compound pooling.
Advanced liquid handling
A suite of industry-leading liquid handling technologies enables highly accurate and reproducible compound transfers at micro- and nanolitre volumes, supporting drug discovery research from screening and hit identification through to lead optimisation.
Contactless 2.5 - 1000 nl transfers to 96-, 384-, and 1536-well microplates from FluidX™ AcoustiX™ microtubes or Echo®-qualified 384- and 1536-well microplates.
Contactless 2.5 - 1000 nl transfers from Echo®-qualified 384-, and 1536-well microplates into 96-, 384-, and 1536-well microplates.
Microliter transfers in whole head or quadranted mode into 96- and 384-well microplates and various 96-microtube racks.
Microliter transfers into 96-, 384-, and 1536-well micro-plates and various 96-microtube racks. Replication, serial diulations, sample solubilitation, and cherry-picking available.
Microliter transfers from SBS 96-microtube racks or 96-, 384-, or 1536- well micoplates into a range of destination microplates in flexible formats (including cherry-picking and serial dilution workflows).
50 nl - 50 µL DMSO dispensed across 96-, 384-, and 1536-wells to deliver fully-configurable plate maps.
“Compounds Australia provided CO-ADD with invaluable service to facilitate the antimicrobial screening of large compound collections from around the world. Compounds Australia produced over 2,000 assay ready plates, which were directly used in CO-ADD’s screening workflow, as well as high quality compound storage of the compounds. Compounds Australia has been an integral part of CO-ADD’s compound handling and screening workflow.“
– Dr Mark BlaskovichProgram Coordinator, Community for Open Antimicrobial Drug Discovery
Explore our capabilities and expertise
Contact details
- Phone
- (07) 3735 4445
- Location and postal address
- Compounds Australia
- Institute for Biomedicine and Glycomics
- Griffith University
- Building N75
- Brisbane Innovation Park
- Don Young Road
- Nathan QLD 4111
